Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eran Broshy Insider Profile
4 Followers
Eran Broshy, Director at Magellan Health, holds 23.02K shares in Certara (Ticker: CERT), holds 80.56K shares in Theravance Biopharma (Ticker: TBPH), holds 9.64K shares in Magellan Health (Ticker: MGLN).
Eran Broshy Magellan Health (MGLN)Director
Magellan Health (MGLN)
Director
Not Ranked
Eran Broshy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Eran Broshy
Eran Broshy's Trading History
Magellan Health
May 25, 2018
―
Uninformative Buy
―
$916.18K
Certara
May 23, 2024
Director
Uninformative Buy
142.94K
$314.03K
Theravance Biopharma
May 10, 2024
Director
Uninformative Buy
―
$686.33K
List of latest transactions for each holding click on a transaction to see Eran Broshy's performance on stock
You May Also Like
Eran Broshy insider profile FAQ
What is the percentage of profitable transactions made by Eran Broshy?
The percentage of profitable transactions made by Eran Broshy is ―.
What is the average return per transaction made by Eran Broshy?
The average return per transaction made by Eran Broshy is ―.
What stocks does Eran Broshy hold?
Eran Broshy holds: MGLN, CERT, TBPH stocks.
What was Eran Broshy’s latest transaction?
Eran Broshy latest transaction was an Uninformative Buy of $142.94K.
What was Eran Broshy's most profitable transaction?
Eran Broshy’s most profitable transaction was an Informative Buy of CERT stock on August 23, 2023. The return on the trade was -13.40%.
What is Eran Broshy's role in Magellan Health?
Eran Broshy's role in Magellan Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.